Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse in Adult ADHD
NCT01070394Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Feb 2010
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by NYU Langone Health. Started Feb 2010; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01070394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01070394.